Logo image of BMNR

BITMINE IMMERSION TECHNOLOGI (BMNR) Stock Fundamental Analysis

NYSEARCA:BMNR - NYSE Arca - US09175A1079 - Common Stock - Currency: USD

58.98  +7.55 (+14.68%)

Premarket: 62.99 +4.01 (+6.8%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BMNR. BMNR was compared to 283 industry peers in the Software industry. BMNR may be in some trouble as it scores bad on both profitability and health. BMNR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BMNR had negative earnings in the past year.
In the past year BMNR has reported a negative cash flow from operations.
BMNR had negative earnings in each of the past 5 years.
In the past 5 years BMNR always reported negative operating cash flow.
BMNR Yearly Net Income VS EBIT VS OCF VS FCFBMNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of BMNR (-87.46%) is worse than 89.05% of its industry peers.
With a Return On Equity value of -229.93%, BMNR is not doing good in the industry: 82.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROIC N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMNR Yearly ROA, ROE, ROICBMNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Gross Margin of BMNR (16.39%) is worse than 83.04% of its industry peers.
BMNR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMNR Yearly Profit, Operating, Gross MarginsBMNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

BMNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BMNR has more shares outstanding
Compared to 1 year ago, BMNR has a worse debt to assets ratio.
BMNR Yearly Shares OutstandingBMNR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BMNR Yearly Total Debt VS Total AssetsBMNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 851.46 indicates that BMNR is not in any danger for bankruptcy at the moment.
BMNR has a Altman-Z score of 851.46. This is amongst the best in the industry. BMNR outperforms 100.00% of its industry peers.
BMNR has a Debt/Equity ratio of 0.90. This is a neutral value indicating BMNR is somewhat dependend on debt financing.
BMNR has a Debt to Equity ratio of 0.90. This is in the lower half of the industry: BMNR underperforms 72.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 851.46
ROIC/WACCN/A
WACC11.46%
BMNR Yearly LT Debt VS Equity VS FCFBMNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

BMNR has a Current Ratio of 0.25. This is a bad value and indicates that BMNR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.25, BMNR is not doing good in the industry: 95.76% of the companies in the same industry are doing better.
A Quick Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
BMNR has a worse Quick ratio (0.25) than 95.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
BMNR Yearly Current Assets VS Current LiabilitesBMNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BMNR have decreased strongly by -100.71% in the last year.
Looking at the last year, BMNR shows a very strong growth in Revenue. The Revenue has grown by 158.36%.
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMNR Yearly Revenue VS EstimatesBMNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BMNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMNR Price Earnings VS Forward Price EarningsBMNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMNR Per share dataBMNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BMNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BITMINE IMMERSION TECHNOLOGI

NYSEARCA:BMNR (8/11/2025, 8:18:53 PM)

Premarket: 62.99 +4.01 (+6.8%)

58.98

+7.55 (+14.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.75%
Ins Owner Change7.37%
Market Cap6.62B
AnalystsN/A
Price Target61.2 (3.76%)
Short Float %3.45%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1432.04
P/FCF N/A
P/OCF N/A
P/B 2321.62
P/tB 2321.62
EV/EBITDA N/A
EPS(TTM)-2.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.04
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.39%
FCFM N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.43%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 851.46
F-Score3
WACC11.46%
ROIC/WACCN/A
Cap/Depr(3y)65716%
Cap/Depr(5y)N/A
Cap/Sales(3y)508.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.32%
OCF growth 3YN/A
OCF growth 5YN/A